Molecular mechanisms for heterologous sensitization of adenylate cyclase

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 1, 2002, Pages 1-7

  Watts, Val J ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; NEUROTRANSMITTER; OPIATE; PERTUSSIS TOXIN; RECOMBINANT ENZYME;

DEPRESSION; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME REGULATION; MENTAL DISEASE; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GTP-BINDING PROTEINS; HUMANS; ISOENZYMES; SUBSTANCE-RELATED DISORDERS;

EID: 0036089264     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.1.1     Document Type: Review

References (43)

1. sα
2. Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment
3. βγ
4. Opiate-induced adenylyl cyclase superactivation is isozyme-specific
5. βγ subunits
6. i/o-coupled receptors: Changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation
7. μ-opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
8. 2a receptors to adenylyl cyclase in the striatum
9. 2 dopamine receptors
10. Agonist regulation of gene expression of adrenergic receptors and G proteins
11. s
12. 1A receptors in P11 cells
13. o
14. 2L cells
15. 2L cells
16. 3H]forskolin binding in membranes from HT29 cells
17. 2-Adrenergic receptor mediated sensitization of forskolin-stimulated cAMP production
18. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological and behavioral evidence for a role in opiate dependence
19. S signaling is intact after disruption of lipid rafts
20. Molecular basis of long-term plasticity underlying addiction
21. Molecular and cellular basis of addiction
22. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors
23. Acute and chronic activation of the μ-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes
24. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase
25. 3 adenosine receptor
26. 2-adrenergic receptor phosphorylation and increases β-adrenergic responsiveness
27. Differential super activation of adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor
28. Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation
29. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior
30. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance
31. Type-specific regulation of mammalian adenylyl cyclases by G protein pathways
32. Unifying perspectives on the mechanisms underlying the development of tolerance and physical dependence to opioids
33. Adenylate cyclase supersensitivity: A general means of cellular adaptation to inhibitory agonists
34. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants
35. Adaptive increase in adenylyl cyclase activity in NG108-15 and S49 cells induced by chronic treatment with inhibitory drugs is not due to a decrease in cAMP concentrations
36. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform
37. Sα from plasma membrane
38. i2 in opioid-induced adenylyl cyclase supersensitization
39. i3
40. 2 dopamine receptors
41. s-insensitive mutants of adenylyl cyclase V
42. 4 dopamine receptors
43. 2L dopamine receptors in NS20Y neuroblastoma cells